SGPCRI

Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) fuels research, funds innovation, and drives global collaboration to fight pancreatic cancer.

[SGPCRI @sgpcri]

Pancreatic cancer has devastated families for decades.

It is often caught at stage 4 because there is no reliable way to detect it earlier. Early detection research is where the most promising breakthroughs are happening.

What early detection research shows the most promise? 💜

[SGPCRI @sgpcri]

The next generation of #PancreaticCancer researchers is in the field right now. Whether they stay depends on funding.

Every researcher who leaves takes potential breakthroughs with them. We refuse to let funding drive the best minds away.

What would a breakthrough mean to you?

[SGPCRI @sgpcri]

Somewhere right now, a researcher is working on a pancreatic cancer problem that most people have written off as too hard, too early, or too far from a result. That's exactly who we're looking to fund.

https://t.co/iMSJmGDBAf

[SGPCRI @sgpcri]

Pancreatic cancer kills more Americans per year than breast cancer.

In 2024, breast cancer received $150 million in federal research funding.

The same year, pancreatic cancer received $15 million.

In 2025, federal funding was cut to zero.

This is the gap we exist to close.

[SGPCRI @sgpcri]

One of the most memorable moments of #ASCO26: a standing ovation following the presentation of the full daraxonrasib results.

This is a powerful reminder of why we do this work and who we’re fighting for.

[SGPCRI @sgpcri]

Grateful to see @SGPCRI Scientific Advisory Board members Drs. Kevan Shokat & Liz Jaffee in the @nytimes on a once‑“impossible” #pancreaticcancer breakthrough. With this momentum building, we’re looking ahead to Dr. Brian Wolpin’s #ASCO26 presentation: https://t.co/GDBiEryG2z

[SGPCRI @sgpcri]

We are filled with deep gratitude and renewed hope as we mark an extraordinary breakthrough in pancreatic cancer research. We're witnessing the beginning of a new era in targeting RAS‑driven cancers.

#PancreaticCancer #CancerResearch #ClinicalTrials

[Revolution Medicines @RevMedicines]

Unprecedented overall survival benefit from Phase 3 RASolute 302 in previously treated metastatic pancreatic cancer.

Read the press release: https://t.co/5deIramAtP

#Oncology #PancreaticCancer

[SGPCRI @sgpcri]

The $1M Stephenson Global Prize is now open for nominations through May 1, celebrating leaders whose discoveries are transforming pancreatic cancer research. Created in honor of Toni Stephenson, this Prize reflects a family’s commitment to a better future: https://t.co/ZtzbkKJ0cK

[SGPCRI @sgpcri]

While we await the 2026 class of Stephenson Scholar Grants recipients, we’re spotlighting 2025 recipients like @MIT's Dr. Matthew Vander Heiden, whose multimodal early‑detection approach uses stool, blood & CT imaging to identify pancreatic cancer sooner: https://t.co/NHdif9HWN3

[SGPCRI @sgpcri]

Nominations are open for the 2026 Stephenson Global Prize, honoring leaders advancing bold, high‑impact pancreatic cancer research.

Know someone driving meaningful scientific progress? Nominate by May 1, 2026 at 5p ET: https://t.co/5UFCunWsnX

#PancreaticCancer #CancerResearch

[SGPCRI @sgpcri]

The Stephenson family helped launch @SGPCRI with a belief that progress in #pancreaticcancer research should move faster and that big ideas deserve the support to grow. Their commitment continues to strengthen innovation & collaboration across the field: https://t.co/DXIpX9GGYv

[SGPCRI @sgpcri]

Nominations for the 2026 Stephenson Global Prize are now open. As the inaugural recipient, @UCSFCancer's Dr. Frank McCormick set the standard with pioneering KRAS research that reshaped #pancreaticcancer early detection and treatment. Nominate by 5/1: https://t.co/5UFCunWsnX

[SGPCRI @sgpcri]

Breakthroughs matter. When @cityofhope patient Chris Parrish heard the words stage 4 pancreatic cancer, she refused to give up. Her resilience reflects why @SGPCRI pushes for faster progress in early detection and treatment: https://t.co/OR1NLqBUfT

#PancreaticCancer

[The Cancer Letter @TheCancerLetter]

The Stephenson Global Pancreatic Cancer Research Institute (@sgpcri), established a little over a year ago with a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and Tessa Stephenson Brand, has refined its goals.
https://t.co/UopHb01SBu

[SGPCRI @sgpcri]

1 DAY LEFT — APPLY NOW! The deadline for the 2026 Stephenson Global Scholar Grants is 2/25 at 5p ET. Inaugural Scholar Dr. Lyssiotis (@UMRogelCancer) exemplifies the visionary, translational research our grant is designed to accelerate: https://t.co/f61Mxpad1f

#PancreaticCancer

[SGPCRI @sgpcri]

There’s still time to apply for the 2026 Stephenson Global Scholar Grants, due 2/25 at 5 PM ET. As one of our 2025 Scholars, @cityofhope's Dr. Sarah Shuck knows how this support accelerates progress toward earlier #PancreaticCancer detection.

Learn more: https://t.co/f61Mxpad1f

[SGPCRI @sgpcri]

$1M. One Prize. Global impact.

The Stephenson Global Prize recognizes groundbreaking achievements advancing pancreatic cancer research and bringing us closer to ending this disease.

Learn more: https://t.co/5UFCunWsnX

[SGPCRI @sgpcri]

On #WorldCancerDay, we honor Toni Lyn Stephenson. A pioneer, visionary, and the inspiration behind @SGPCRI. We are grateful for all the extraordinary clinicians and scientists around the world working every day to change the trajectory of pancreatic cancer.

[SGPCRI @sgpcri]

We're now accepting applications for our 2026 Stephenson Global Scholar Grants — supporting innovative, high-risk, high-reward ideas that can change the trajectory of pancreatic cancer.

Apply: https://t.co/f61Mxpad1f
Press release: https://t.co/iqbsrnyZ9b

#StephensonScholars

[Maya Inspired @Maya4Rights]

@sgpcri @kevansf The Stephenson Symposium's focus on collaboration and $5.3M in grants shows exactly how we accelerate pancreatic cancer breakthroughs. Dr. McCormick's work gives real hope. 💪